ATE182176T1 - Dna, welche für den vorläufer des interleukin-1 beta konvertierenden enzyms kodiert (ice rel-ii) - Google Patents
Dna, welche für den vorläufer des interleukin-1 beta konvertierenden enzyms kodiert (ice rel-ii)Info
- Publication number
- ATE182176T1 ATE182176T1 AT95914256T AT95914256T ATE182176T1 AT E182176 T1 ATE182176 T1 AT E182176T1 AT 95914256 T AT95914256 T AT 95914256T AT 95914256 T AT95914256 T AT 95914256T AT E182176 T1 ATE182176 T1 AT E182176T1
- Authority
- AT
- Austria
- Prior art keywords
- icerel
- cdna
- recombinant
- interleukin
- precursor
- Prior art date
Links
- 108090000426 Caspase-1 Proteins 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
- 108020004635 Complementary DNA Proteins 0.000 abstract 6
- 238000010804 cDNA synthesis Methods 0.000 abstract 6
- 239000002299 complementary DNA Substances 0.000 abstract 6
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 230000006870 function Effects 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/225,487 US6110701A (en) | 1994-04-08 | 1994-04-08 | DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE182176T1 true ATE182176T1 (de) | 1999-07-15 |
Family
ID=22845077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95914256T ATE182176T1 (de) | 1994-04-08 | 1995-04-04 | Dna, welche für den vorläufer des interleukin-1 beta konvertierenden enzyms kodiert (ice rel-ii) |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6110701A (de) |
| EP (1) | EP0754234B1 (de) |
| JP (1) | JP3750136B2 (de) |
| AT (1) | ATE182176T1 (de) |
| CA (1) | CA2187161C (de) |
| DE (1) | DE69510782T2 (de) |
| DK (1) | DK0754234T3 (de) |
| ES (1) | ES2136285T3 (de) |
| GR (1) | GR3031468T3 (de) |
| WO (1) | WO1995027793A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7250494A (en) * | 1994-06-23 | 1996-01-19 | Human Genome Sciences, Inc. | Interleukin-1 beta converting enzyme like apoptosis protease-1 and 2 |
| FR2723378B1 (fr) * | 1994-08-02 | 1996-10-31 | Roussel Uclaf | Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications |
| WO1996026280A1 (en) * | 1995-02-21 | 1996-08-29 | Basf Aktiengesellschaft | NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME |
| US6121018A (en) * | 1997-03-27 | 2000-09-19 | Smithkline Beecham Corporation | Interleukin-1β converting enzyme like apoptosis protease-10 |
| PL366134A1 (en) | 2000-06-15 | 2005-01-24 | Smithkline Beecham Corporation | Method for preparing a physiologically active il-18 polypeptide |
| CN115772220B (zh) * | 2022-11-22 | 2023-08-11 | 武汉爱博泰克生物科技有限公司 | 针对人白介素-1β的兔单克隆抗体及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5416013A (en) * | 1990-04-04 | 1995-05-16 | Sterling Winthrop Inc. | Interleukin 1β protease and interleukin 1β protease inhibitors |
| WO1993025685A1 (en) * | 1992-06-12 | 1993-12-23 | Massachusetts Institute Of Technology | Cloning and characterization of the cell death genes ced-3 and ced-4 |
| JPH08500482A (ja) * | 1992-06-12 | 1996-01-23 | マサチューセッツ インスティテュート オブ テクノロジー | Ｃｅｄ−３及び関連蛋白質のインヒビター |
-
1994
- 1994-04-08 US US08/225,487 patent/US6110701A/en not_active Expired - Fee Related
-
1995
- 1995-04-04 DE DE69510782T patent/DE69510782T2/de not_active Expired - Lifetime
- 1995-04-04 AT AT95914256T patent/ATE182176T1/de not_active IP Right Cessation
- 1995-04-04 EP EP95914256A patent/EP0754234B1/de not_active Expired - Lifetime
- 1995-04-04 ES ES95914256T patent/ES2136285T3/es not_active Expired - Lifetime
- 1995-04-04 WO PCT/CA1995/000188 patent/WO1995027793A1/en not_active Ceased
- 1995-04-04 US US08/721,986 patent/US6103513A/en not_active Expired - Fee Related
- 1995-04-04 CA CA002187161A patent/CA2187161C/en not_active Expired - Fee Related
- 1995-04-04 DK DK95914256T patent/DK0754234T3/da active
- 1995-04-04 JP JP52599295A patent/JP3750136B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-08 GR GR990402559T patent/GR3031468T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69510782D1 (de) | 1999-08-19 |
| DE69510782T2 (de) | 1999-12-30 |
| US6110701A (en) | 2000-08-29 |
| JP3750136B2 (ja) | 2006-03-01 |
| CA2187161C (en) | 2008-02-05 |
| DK0754234T3 (da) | 1999-11-29 |
| JPH09511646A (ja) | 1997-11-25 |
| WO1995027793A1 (en) | 1995-10-19 |
| EP0754234B1 (de) | 1999-07-14 |
| CA2187161A1 (en) | 1995-10-19 |
| ES2136285T3 (es) | 1999-11-16 |
| GR3031468T3 (en) | 2000-01-31 |
| EP0754234A1 (de) | 1997-01-22 |
| US6103513A (en) | 2000-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE393227T1 (de) | Klonierung und charakterisierung von napsin, einer aspartat-protease | |
| ATE484587T1 (de) | Ldcam genannte moleküle | |
| ATE415480T1 (de) | B7l-1 moleküle | |
| EP0653940A4 (de) | Glialmitogene faktoren, ihre herstellung und verwendung. | |
| AU603983B2 (en) | Expression of factor vii and ix activities in mammalian cells | |
| WO1995009872B1 (en) | Dna encoding prostaglandin receptor ip | |
| NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
| ATE338821T1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
| WO1995000551B1 (en) | Prostaglandin receptor fp and dna encoding it | |
| ATE182177T1 (de) | Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert | |
| DE69510782D1 (de) | DNA, WELCHE FÜR DEN VORLÄUFER DES INTERLEUKIN-1 BETA KONVERTIERENDEN ENZYMS KODIERT (ICE rel-II) | |
| ATE121457T1 (de) | Für das menschliche angiotension-umformungsenzym (ace) kodierende nukleinsäure und ihre anwendungen, insbesondere zur in-vitro-diagnose von bluthochdruck. | |
| DE69433385D1 (de) | Für die untereinheiten der 1,3-beta-d-glucansynthase kodierende dna | |
| Tanabe et al. | Degradation of enamelins by proteinases found in porcine secretory enamel in vitro | |
| TR200201119T2 (tr) | İnsan alfa1G-C-türü kalsiyum kanalı kodlayan DNA. | |
| EP0785716A4 (de) | Als lerk6 bezeichnetes cytokin | |
| US4923818A (en) | DNA clone of human type IV collagenase | |
| Tanzer et al. | Inhibitory effects of tunacamycin on procollagen biosynthesis and secretion | |
| DE69535232D1 (de) | DNA-SEQUENZEN, DIE FÜR DIE MENSCHLICHE PROTEINE Tx UND Ty KODIEREN, DIE ICE GLEICHEN | |
| Drzymala et al. | Cellular phosphorylation of an acidic proline-rich protein, PRP1, a secreted salivary phosphoprotein | |
| WO2004060867A3 (en) | Secreted protein factor and cell membrane-bound splice variant | |
| ATE266094T1 (de) | Produktion des proteins ingap mit hoher expressionsrate | |
| CA1339874C (en) | Dna clone of human type iv collagenase | |
| CA2246430A1 (en) | Protein tyrosine phosphatases of hematopoietic cells | |
| DE69831242D1 (de) | Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |